ArticleBMC research notes2026
Vulvovaginal tumors and pseudo-tumors: a clinicopathological analysis of 57 cases.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe vulva and vagina can be affected by a variety of lesions. The pathology of these organs has gained little attention in the literature compared to other gynecological organs. Our aim was to report clinical and pathological features of vulvovaginal tumors and pseudo-tumors (tumor-like lesions). We performed a retrospective study including consecutive vulvovaginal tumors and pseudo-tumors diagnosed at a single tertiary care center.
resultsWe have registered 57 cases of vulvovaginal tumors and pseudo-tumors, with 30 cases (52.6%) from the vulva. The mean age was 38.55 years ± 16.65 (range of 5 months and 72 years), tumors were mostly cystic (17/30 cases, 56.7%) with a mean size of 3.9 cm ± 2.07 (range of 0.8 and 9 cm). There were 34 cases (59.6%) of benign lesions mostly Bartholin cysts (19.3%). The remaining cases were malignant tumors (23 patients, 40.4%) representing 12.7% of all gynecological cancers. Malignant tumors were mostly vaginal metastatic carcinomas (15 cases, 26.3%) from neighboring organs. Patients with vaginal lesions were older than those with vulvar lesions (43.64 years versus 34.01; p = 0.034). The vast majority of vaginal lesions were malignant in contrast to vulvar lesions (70.4% versus 13.4%; p < 0.001).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.